Cite
Martini DJ, Olsen TA, Goyal S, et al. Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors. Front Oncol. 2021;11:707050doi: 10.3389/fonc.2021.707050.
Martini, D. J., Olsen, T. A., Goyal, S., Liu, Y., Evans, S. T., Magod, B., Brown, J. T., Yantorni, L., Russler, G. A., Caulfield, S., Goldman, J. M., Nazha, B., Kissick, H. T., Harris, W. B., Kucuk, O., Carthon, B. C., Master, V. A., & Bilen, M. A. (2021). Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors. Frontiers in oncology, 11707050. https://doi.org/10.3389/fonc.2021.707050
Martini, Dylan J, et al. "Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors." Frontiers in oncology vol. 11 (2021): 707050. doi: https://doi.org/10.3389/fonc.2021.707050
Martini DJ, Olsen TA, Goyal S, Liu Y, Evans ST, Magod B, Brown JT, Yantorni L, Russler GA, Caulfield S, Goldman JM, Nazha B, Kissick HT, Harris WB, Kucuk O, Carthon BC, Master VA, Bilen MA. Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors. Front Oncol. 2021 Jul 09;11:707050. doi: 10.3389/fonc.2021.707050. eCollection 2021. PMID: 34307176; PMCID: PMC8299332.
Copy
Download .nbib